Lowest-Rated StocksLowest-RatedNASDAQ:SILK Silk Road Medical (SILK) Stock Price, News & Analysis → 8,788% Return Predicted For THIS Crypto (already up 40% in 6 months) (From Paradigm Press) (Ad) Free SILK Stock Alerts $16.99 +1.14 (+7.19%) (As of 03/18/2024 ET) Add Compare Share Share Today's Range$15.71▼$17.0950-Day Range$12.93▼$18.2552-Week Range$6.08▼$46.57Volume889,676 shsAverage Volume930,526 shsMarket Capitalization$665.50 millionP/E RatioN/ADividend YieldN/APrice Target$22.18 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Silk Road Medical alerts: Email Address Silk Road Medical MarketRank™ Stock AnalysisAnalyst RatingHold2.18 Rating ScoreUpside/Downside30.6% Upside$22.18 Price TargetShort InterestBearish11.03% of Shares Sold ShortDividend StrengthN/ASustainability-0.74Upright™ Environmental ScoreNews Sentiment0.57Based on 8 Articles This WeekInsider TradingSelling Shares$351,247 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($1.39) to ($1.29) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.14 out of 5 starsMedical Sector188th out of 947 stocksSurgical & Medical Instruments Industry22nd out of 99 stocks 4.1 Analyst's Opinion Consensus RatingSilk Road Medical has received a consensus rating of Hold. The company's average rating score is 2.18, and is based on 4 buy ratings, 5 hold ratings, and 2 sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $22.18, Silk Road Medical has a forecasted upside of 30.6% from its current price of $16.99.Amount of Analyst CoverageSilk Road Medical has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 1.0 Short Interest Percentage of Shares Shorted11.03% of the outstanding shares of Silk Road Medical have been sold short.Short Interest Ratio / Days to CoverSilk Road Medical has a short interest ratio ("days to cover") of 4.8.Change versus previous monthShort interest in Silk Road Medical has recently increased by 20.00%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldSilk Road Medical does not currently pay a dividend.Dividend GrowthSilk Road Medical does not have a long track record of dividend growth. Previous Next 4.3 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreSilk Road Medical has received a 62.88% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is driven by its "Surgical instruments" and "Medical devices engineering" products. See details.Environmental SustainabilityThe Environmental Impact score for Silk Road Medical is -0.74. Previous Next 2.5 News and Social Media Coverage News SentimentSilk Road Medical has a news sentiment score of 0.57. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Silk Road Medical this week, compared to 3 articles on an average week.Search InterestOnly 3 people have searched for SILK on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows3 people have added Silk Road Medical to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Silk Road Medical insiders have sold 76.70% more of their company's stock than they have bought. Specifically, they have bought $198,783.00 in company stock and sold $351,247.00 in company stock.Percentage Held by InsidersOnly 6.70% of the stock of Silk Road Medical is held by insiders. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Silk Road Medical are expected to grow in the coming year, from ($1.39) to ($1.29) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Silk Road Medical is -11.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Silk Road Medical is -11.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSilk Road Medical has a P/B Ratio of 4.38. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Paradigm Press8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)THIS cryptocurrency has gained 40% in 6 months. A crypto millionaire who has researched the space for a decade says it will go up 8,788% in 5 years. The name of this cryptocurrency is revealed right here: Click to get the name of the cryptocurrency About Silk Road Medical Stock (NASDAQ:SILK)Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a specialty balloon for the TCAR procedure. Silk Road Medical, Inc. was incorporated in 2007 and is headquartered in Sunnyvale, California.Read More SILK Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SILK Stock News HeadlinesMarch 17, 2024 | insidertrades.comSilk Road Medical, Inc (NASDAQ:SILK) Director Kevin J. Ballinger Acquires 11,700 SharesMarch 18, 2024 | americanbankingnews.comSilk Road Medical, Inc (NASDAQ:SILK) Given Consensus Recommendation of "Hold" by AnalystsMarch 19, 2024 | Behind the Markets (Ad)The only AI company you should be looking atThis is the ONLY AI company you should be watching right now. No. It's not Nvidia, Intel, or Microsoft... It's a tiny biotech using proprietary AI to assist in new drug discovery at a rate 100,000 times faster than a human. This new drug discovery technique will change the market. And that's why they received a $50 million investment from an AI powerhouse.March 15, 2024 | finance.yahoo.comSILK Oct 2024 25.000 callMarch 15, 2024 | finance.yahoo.comSILK Jul 2024 25.000 callMarch 11, 2024 | yahoo.comWhy now’s the time to discover Uzbekistan – before it turns into DubaiMarch 10, 2024 | americanbankingnews.comInsider Buying: Silk Road Medical, Inc (NASDAQ:SILK) Director Purchases $198,783.00 in StockMarch 9, 2024 | americanbankingnews.comArgus Upgrades Silk Road Medical (NASDAQ:SILK) to BuyMarch 19, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.March 7, 2024 | msn.comArgus upgrades Silk Road Medical to buy, cites expanding footprintMarch 7, 2024 | realmoney.thestreet.comArgus gets more bullish on Silk Road Medical, upgrades sharesMarch 7, 2024 | realmoney.thestreet.comArgus upgrades Silk Road Medical to Buy amid expanding commercial footprintMarch 7, 2024 | finance.yahoo.comSilk Road Medical, Inc: Upgrading to BUY with a target of $24March 7, 2024 | msn.comSilk Road Medical's (SILK) New Stent Expands Its TCAR PortfolioMarch 5, 2024 | globenewswire.comSilk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent SystemMarch 2, 2024 | finance.yahoo.comSilk Road Medical, Inc (NASDAQ:SILK) Released Earnings Last Week And Analysts Lifted Their Price Target To US$18.43March 1, 2024 | finance.yahoo.comSilk Road Medical Full Year 2023 Earnings: Beats ExpectationsFebruary 29, 2024 | markets.businessinsider.comBreaking Down Silk Road Medical: 5 Analysts Share Their ViewsFebruary 29, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Castle Biosciences (CSTL), DENTSPLY SIRONA (XRAY) and Silk Road Medical (SILK)February 29, 2024 | finance.yahoo.comSilk Road Medical, Inc (NASDAQ:SILK) Q4 2023 Earnings Call TranscriptFebruary 29, 2024 | finance.yahoo.comQ4 2023 Silk Road Medical Inc Earnings CallFebruary 28, 2024 | benzinga.comSilk Road Medical: Q4 Earnings InsightsFebruary 28, 2024 | markets.businessinsider.comSilk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial OutlookFebruary 28, 2024 | finance.yahoo.comSilk Road Medical Inc (SILK) Reports Growth Amidst Increased Adoption of TCARFebruary 28, 2024 | globenewswire.comSilk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial OutlookFebruary 28, 2024 | investing.comSilk Road Medical Inc (SILK)February 27, 2024 | msn.comSilk Road Medical Q4 2023 Earnings PreviewSee More Headlines Receive SILK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Silk Road Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/28/2024Today3/19/2024Next Earnings (Estimated)5/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:SILK CUSIPN/A CIK1397702 Webwww.silkroadmed.com Phone(408) 720-9002Fax408-720-9013Employees414Year FoundedN/APrice Target and Rating Average Stock Price Target$22.18 High Stock Price Target$47.00 Low Stock Price Target$8.00 Potential Upside/Downside+30.6%Consensus RatingHold Rating Score (0-4)2.18 Research Coverage11 Analysts Profitability EPS (Most Recent Fiscal Year)($1.44) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-55,740,000.00 Net Margins-31.70% Pretax Margin-31.47% Return on Equity-36.38% Return on Assets-21.41% Debt Debt-to-Equity Ratio0.50 Current Ratio7.95 Quick Ratio6.97 Sales & Book Value Annual Sales$177.13 million Price / Sales3.76 Cash FlowN/A Price / Cash FlowN/A Book Value$3.88 per share Price / Book4.38Miscellaneous Outstanding Shares39,170,000Free Float36,550,000Market Cap$665.50 million OptionableOptionable Beta1.48 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Lucas W. Buchanan (Age 46)CFO & COO Comp: $870.55kMr. Kevin M. Klemz (Age 63)EVP, Chief Legal Officer & Secretary Comp: $644.12kMr. Andrew S. Davis (Age 55)Chief Commercial Officer Comp: $836.33kMr. Richard M. Ruedy (Age 57)Executive Vice President of Clinical, Regulatory Affairs & Quality Assurance Comp: $542.41kMr. Charles S. McKhann (Age 55)Chief Executive Officer Ms. Mhairi L. Jones (Age 53)Chief Accounting Officer & VP of Finance Ms. Tammy LeitsingerCompliance Officer & VP of Medical AffairsMs. Alison HighlanderVice President of Human ResourcesDr. Sumaira MacDonald M.D.Ph.D., Executive Medical DirectorLynn LewisInvestors Relations OfficerMore ExecutivesKey CompetitorsOrthoPediatricsNASDAQ:KIDSPulse BiosciencesNASDAQ:PLSEIRadimedNASDAQ:IRMDNevroNYSE:NVROSI-BONENASDAQ:SIBNView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Sold 684,732 shares on 3/11/2024Ownership: 7.383%Lucas W BuchananSold 9,877 sharesTotal: $169,588.09 ($17.17/share)Andrew S DavisSold 5,481 sharesTotal: $94,108.77 ($17.17/share)Kevin M KlemzSold 2,497 sharesTotal: $42,873.49 ($17.17/share)Marie L JonesSold 2,602 sharesTotal: $44,676.34 ($17.17/share)View All Insider TransactionsView All Institutional Transactions SILK Stock Analysis - Frequently Asked Questions Should I buy or sell Silk Road Medical stock right now? 11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last twelve months. There are currently 2 sell ratings, 5 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" SILK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SILK, but not buy additional shares or sell existing shares. View SILK analyst ratings or view top-rated stocks. What is Silk Road Medical's stock price target for 2024? 11 brokers have issued 1-year price objectives for Silk Road Medical's shares. Their SILK share price targets range from $8.00 to $47.00. On average, they expect the company's stock price to reach $22.18 in the next year. This suggests a possible upside of 30.6% from the stock's current price. View analysts price targets for SILK or view top-rated stocks among Wall Street analysts. How have SILK shares performed in 2024? Silk Road Medical's stock was trading at $12.27 on January 1st, 2024. Since then, SILK shares have increased by 38.5% and is now trading at $16.99. View the best growth stocks for 2024 here. Are investors shorting Silk Road Medical? Silk Road Medical saw a increase in short interest in February. As of February 29th, there was short interest totaling 4,320,000 shares, an increase of 20.0% from the February 14th total of 3,600,000 shares. Based on an average trading volume of 907,100 shares, the short-interest ratio is presently 4.8 days. View Silk Road Medical's Short Interest. When is Silk Road Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our SILK earnings forecast. How were Silk Road Medical's earnings last quarter? Silk Road Medical, Inc (NASDAQ:SILK) posted its quarterly earnings results on Wednesday, February, 28th. The company reported ($0.33) earnings per share for the quarter, topping analysts' consensus estimates of ($0.40) by $0.07. The business earned $47.27 million during the quarter, compared to the consensus estimate of $42.23 million. Silk Road Medical had a negative net margin of 31.70% and a negative trailing twelve-month return on equity of 36.38%. What ETFs hold Silk Road Medical's stock? ETFs with the largest weight of Silk Road Medical (NASDAQ:SILK) stock in their portfolio include American Century Focused Dynamic Growth ETF (FDG).iShares U.S. Medical Devices ETF (IHI). What guidance has Silk Road Medical issued on next quarter's earnings? Silk Road Medical updated its FY 2024 earnings guidance on Wednesday, February, 28th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $194.0 million-$198.0 million, compared to the consensus revenue estimate of $191.7 million. What other stocks do shareholders of Silk Road Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include RTX (RTX), Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA). When did Silk Road Medical IPO? (SILK) raised $75 million in an initial public offering (IPO) on Thursday, April 4th 2019. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch acted as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers. Who are Silk Road Medical's major shareholders? Silk Road Medical's stock is owned by many different institutional and retail investors. Top institutional shareholders include Wasatch Advisors LP (10.40%), Vanguard Group Inc. (7.43%), Vanguard Group Inc. (7.38%), Goldman Sachs Group Inc. (5.16%), Goldman Sachs Group Inc. (5.16%) and Armistice Capital LLC (4.54%). Insiders that own company stock include Andrew S Davis, Andrew S Davis, Elizabeth H Weatherman, Erica J Rogers, Erica J Rogers, Jack W Lasersohn, Kevin J Ballinger, Kevin M Klemz, Lucas W Buchanan, Marie L Jones, Richard Ruedy and Tony M Chou. View institutional ownership trends. How do I buy shares of Silk Road Medical? Shares of SILK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:SILK) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressAltcoin FRENZY Alert…Crypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silk Road Medical, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.